Ethanol emissions
A technique has been developed that allows scientists to track urban atmospheric plumes from manmade biofuels using a unique isotopic signature found in vehicle emissions.
A technique has been developed that allows scientists to track urban atmospheric plumes from manmade biofuels using a unique isotopic signature found in vehicle emissions.
Ethanol is used in making biofuels and as these fuels become more widely used, interest in their influence on air quality is increasing. When biofuels are burnt the remaining ethanol emitted as exhaust has a much higher 13C to 12C ratio than the ethanol naturally emitted by tropical plants. A study published in Environmental Science & Technology has suggested that this signature can be used to track plumes as they drift away from urban areas.1
The researchers collected and analysed air from downtown Miami, Florida, USA, and the nearby Everglades National Park. The components of the air samples from the two locations were first separated using gas chromatography, before the abundance of each carbon isotope was measured via a mass spectrometer. The study found that 75% of ethanol in Miami’s urban air came from manmade biofuels, while the majority of ethanol in the Everglades air was emitted from plants, even though a small quantity of city pollution from a nearby road floats into the park.
It is estimated that plants currently release three times as much ethanol as manmade sources but the authors of the study warn that as the amount of ethanol used in fuels increases this should change.
1. B.M. Giebel, P.K. Swart and D.D. Riemer, Environ. Sci. Technol., 45(15), 6661–6669 (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
